UK markets closed

EssilorLuxottica Société anonyme (EL.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
139.88+1.74 (+1.26%)
At close: 5:37PM CEST
Full screen
Previous close138.14
Open139.36
Bid0.00 x 0
Ask0.00 x 0
Day's range138.60 - 139.88
52-week range103.05 - 143.10
Volume306,172
Avg. volume528,144
Market cap61.243B
Beta (5Y monthly)0.89
PE ratio (TTM)736.21
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.23 (1.62%)
Ex-dividend date28 May 2021
1y target estN/A
  • Ray-Ban maker EssilorLuxottica lifts quarterly sales with China, U.S. help
    Reuters

    Ray-Ban maker EssilorLuxottica lifts quarterly sales with China, U.S. help

    Increased demand in the United States helped by stimulus checks and strong Chinese sales in myopia control lenses offset disruptions due to U.S. storms and renewed restrictions in Europe during the quarter due to another COVID-19 spike. EssilorLuxottica saw a "solid trend" in North America in April while business in Asia was growing at a "strong pace", co-Chief Financial Officer Stefano Grassi told analysts on a call. The company, which makes sunglasses and spectacle frames for brands such as Chanel, Prada and Versace, usually benefits from the rising need for prescription glasses in aging population and from more time spent on screens.

  • EssiLux loses court appeal against takeover target GrandVision
    Reuters

    EssiLux loses court appeal against takeover target GrandVision

    Spectacles maker EssilorLuxottica on Tuesday lost an appeal in its court battle with takeover target GrandVision, removing a possible hurdle for the 7.2 billion euro ($8.5 billion) deal. EssilorLuxottica in August last year lost a Dutch court case in which it had said that GrandVision's decisions to suspend payments to store owners and suppliers and to apply for state aid could give grounds for ending its proposed takeover. The Rotterdam district court at the time said EssiLux had failed to prove its claim that the Dutch operator of eyewear stores had breached the takeover agreement by not asking permission for the actions it took as lockdowns to combat COVID-19 spread throughout Europe.

  • EssilorLuxottica aims recovery to pre-pandemic levels in 2021
    Reuters

    EssilorLuxottica aims recovery to pre-pandemic levels in 2021

    The eyewear maker said positive momentum was already visible in the Asia-Pacific region and that it expected the roll-out of vaccines to start normalizing the business environment in the second quarter. Its sales rose 1.7% in the fourth quarter at constant currencies to 4.11 billion euros ($4.92 billion), as a rebound in its prescription glasses business offset weak demand for sunglasses from customers staying at home due to the pandemic. EssilorLuxottica said it expected that trend to continue this year, along with the rise in e-commerce sales.